Ranolazine Production Cost Reports

The report provides a detailed analysis essential for establishing a Ranolazine production plant. It encompasses all critical aspects necessary for Ranolazine production, including the cost of Ranolazine production, Ranolazine plant cost, Ranolazine production costs, and the overall Ranolazine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Ranolazine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Ranolazine is used for the treatment of chronic angina, a condition resulting from reduced blood flow to the heart characterized by chest pain. It is used alone or in combination with other anti-anginal drugs that include sublingual nitrates and beta-blockers, as well as calcium channel blockers, long-acting nitrate therapy, ivabradine, angiotensin receptor blockers (ARB), ACE inhibitors, and lipid-lowering therapies. It works by increasing the efficiency with which the heart uses oxygen, allowing it to do more work with less oxygen. It also helps in preventing atrial fibrillation. It is taken orally as an extended-release tablet, usually taken twice daily with or without food. It carries a risk of heart rhythm problems that are intensified in patients with liver impairment.

The market for Ranolazine is driven by several key factors. Its increasing demand as an anti-angina medication and the growing incidence of cardiovascular diseases worldwide contribute to its growing demand. Its use alone or in combination with a variety of other medications makes it a popular product among healthcare providers. The rising cases of obesity and diabetes that amplify angina and other cardiovascular disorders further contribute to its demand.

Consumers’ preference for safe and effective symptom-relieving drugs, along with its inclusion in hospital formularies coupled with ePharmacy availability that supports accessibility, adds up to its market. Thus, industrial Ranolazine procurement is affected by its increasing demand as an anti-angina medication, increasing cardiovascular disease cases, along with safety and effectivity, and enhanced accessibility.

Raw Material for Ranolazine Production

According to the Ranolazine production plant project report, the key raw materials used in the production of Ranolazine include Amines-Acyl Anhydride-Acyl Chloride-Piperazine.

Manufacturing Process of Ranolazine

The extensive Ranolazine production cost report consists of the following major industrial production process:

1. From Amines, Acyl Anhydride, Acyl Chlorides, and Piperazine: The production of Ranolazine involves several steps. First, N-acylation of amine takes place by using acyl anhydride, followed by N-acylation of amine with acyl chloride in an aqueous solution. After that, the compound goes through N-alkylation and deprotection, followed by mono-alkylation of piperazine, forming Ranolazine.

Ranolazine's molecular formula is C24H33N3O4, and it has a molar mass of 427.54 g/mol. It is an off-white to white solid powder with a melting point in two different ranges, 120-124 °C and 164-166 °C. Its log P value is 2.07, making it moderately lipophilic in nature, and it is soluble in organic solvents. Its acidic and basic pKa values are 2.2 and 6.77, respectively. Its mean apparent volume of distribution is 53.2 L, with steady-state volume of distribution ranging between 85 to 180 L. Around 62% of the drug binds to plasma proteins, and its dosing frequency is twice daily due to its terminal half-life of around 7 hours. All these physical and chemical properties contribute to its pharmacological profile and use in chronic anti-anginal treatment.